| 25.2 0 (0%) | 06-17 09:41 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Hercules Capital, Inc. operates as a Business Development Company (BDC), specializing in providing capital to high-growth companies. It primarily offers venture debt, senior secured loans, and growth capital to privately held, venture capital-backed enterprises across all stages of development, from nascent startups to established businesses. The firm also selectively partners with publicly traded companies and lower middle-market firms seeking funds for acquisitions, recapitalizations, or refinancing. Hercules Capital provides a comprehensive suite of financing solutions tailored for various corporate objectives: Growth & Expansion: This includes capital extensions, management buy-outs, corporate spin-outs, financing for company, asset, or intellectual property acquisitions, and support for both domestic and international corporate expansion, vendor financing, and initiatives for revenue acceleration through sales, marketing, and manufacturing development. Asset-Based Lending: Focused on cash flow, these solutions encompass accounts receivable facilities, equipment loans or leases (for acquisition or facility build-out/expansion), and revolving lines of credit for working capital and inventory needs. Strategic & Bridge Financing: The firm supports critical transitions such as bridge financing to IPOs or M&A, technology acquisitions, dividend recapitalizations, and other investor liquidity events. It also offers cash flow financing to mitigate share price volatility, funding for competitor acquisitions, pre-IPO financing for balance sheet enhancement, public company financing for continued asset growth, short-term bridge loans, and financing for strategic and intellectual property acquisitions. Additionally, Hercules Capital structures convertible, subordinated, and mezzanine loans. The firm's primary investment strategy involves structured debt coupled with warrants, though it also participates in senior debt and, to a lesser extent, direct equity investments. It generally seeks companies that have been operational for at least 6 to 12 months prior to investment. Hercules Capital shows a strong preference for specific sectors, including technology (spanning software, hardware, digital media, security, business services), energy technology (such as clean tech, renewables, smart grid), and life sciences (including biopharmaceuticals, medical devices, and diagnostics). Educational services also fall within its investment scope. Geographically, Hercules Capital predominantly invests in U.S.-based companies, with a particular focus on the West Coast, Mid-Atlantic, Southeast, and Midwest regions, especially for software, biotech, and information services businesses. While equity investments can range from $10 million to $250 million per transaction, typical financing for companies in business services, communications, electronics, hardware, and healthcare services ranges between $1 million and $40 million. Although its portfolio mainly consists of private companies, it also holds investments in public entities. For direct equity investments, the firm may pursue a significant stake, potentially exceeding 25% of voting securities. A portion of its assets is dedicated to equipment-based loans for early-stage companies, generally up to $3 million, with an allowance of up to $15 million for specific energy technology ventures. Many of its debt instruments include an option for conversion into equity. The firm also actively co-invests with other private equity firms. Hercules Capital aims for investment exits through various avenues, including initial public offerings (IPOs), private sales of equity interests to third parties, mergers or acquisitions of the portfolio company, or buybacks of the equity position by the company or its shareholders. Investment horizons vary: structured debt with warrants typically matures within 2-7 years (averaging three years), senior debt within three years, equipment loans between three and four years, and equity-related securities between three and seven years. The company utilizes its balance sheet capital for these investments. Founded in December 2003, Hercules Capital, Inc. was formerly known as Hercules Technology Growth Capital, Inc. It is headquartered in Palo Alto, California, and maintains numerous offices across the U.S., including Boston, San Diego, New York, and Washington D.C., along with an international office in London, United Kingdom.
Mon, 23 Mar 2020
Hercules Capital Business and Coronavirus Update - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |